28 research outputs found

    image_4_Hookworm Secreted Extracellular Vesicles Interact With Host Cells and Prevent Inducible Colitis in Mice.tif

    No full text
    <p>Gastrointestinal (GI) parasites, hookworms in particular, have evolved to cause minimal harm to their hosts, allowing them to establish chronic infections. This is mediated by creating an immunoregulatory environment. Indeed, hookworms are such potent suppressors of inflammation that they have been used in clinical trials to treat inflammatory bowel diseases (IBD) and celiac disease. Since the recent description of helminths (worms) secreting extracellular vesicles (EVs), exosome-like EVs from different helminths have been characterized and their salient roles in parasite–host interactions have been highlighted. Here, we analyze EVs from the rodent parasite Nippostrongylus brasiliensis, which has been used as a model for human hookworm infection. N. brasiliensis EVs (Nb-EVs) are actively internalized by mouse gut organoids, indicating a role in driving parasitism. We used proteomics and RNA-Seq to profile the molecular composition of Nb-EVs. We identified 81 proteins, including proteins frequently present in exosomes (like tetraspanin, enolase, 14-3-3 protein, and heat shock proteins), and 27 sperm-coating protein-like extracellular proteins. RNA-Seq analysis revealed 52 miRNA species, many of which putatively map to mouse genes involved in regulation of inflammation. To determine whether GI nematode EVs had immunomodulatory properties, we assessed their potential to suppress GI inflammation in a mouse model of inducible chemical colitis. EVs from N. brasiliensis but not those from the whipworm Trichuris muris or control vesicles from grapes protected against colitic inflammation in the gut of mice that received a single intraperitoneal injection of EVs. Key cytokines associated with colitic pathology (IL-6, IL-1β, IFNγ, and IL-17a) were significantly suppressed in colon tissues from EV-treated mice. By contrast, high levels of the anti-inflammatory cytokine IL-10 were detected in Nb-EV-treated mice. Proteins and miRNAs contained within helminth EVs hold great potential application in development of drugs to treat helminth infections as well as chronic non-infectious diseases resulting from a dysregulated immune system, such as IBD.</p

    image_3_Hookworm Secreted Extracellular Vesicles Interact With Host Cells and Prevent Inducible Colitis in Mice.tif

    No full text
    <p>Gastrointestinal (GI) parasites, hookworms in particular, have evolved to cause minimal harm to their hosts, allowing them to establish chronic infections. This is mediated by creating an immunoregulatory environment. Indeed, hookworms are such potent suppressors of inflammation that they have been used in clinical trials to treat inflammatory bowel diseases (IBD) and celiac disease. Since the recent description of helminths (worms) secreting extracellular vesicles (EVs), exosome-like EVs from different helminths have been characterized and their salient roles in parasite–host interactions have been highlighted. Here, we analyze EVs from the rodent parasite Nippostrongylus brasiliensis, which has been used as a model for human hookworm infection. N. brasiliensis EVs (Nb-EVs) are actively internalized by mouse gut organoids, indicating a role in driving parasitism. We used proteomics and RNA-Seq to profile the molecular composition of Nb-EVs. We identified 81 proteins, including proteins frequently present in exosomes (like tetraspanin, enolase, 14-3-3 protein, and heat shock proteins), and 27 sperm-coating protein-like extracellular proteins. RNA-Seq analysis revealed 52 miRNA species, many of which putatively map to mouse genes involved in regulation of inflammation. To determine whether GI nematode EVs had immunomodulatory properties, we assessed their potential to suppress GI inflammation in a mouse model of inducible chemical colitis. EVs from N. brasiliensis but not those from the whipworm Trichuris muris or control vesicles from grapes protected against colitic inflammation in the gut of mice that received a single intraperitoneal injection of EVs. Key cytokines associated with colitic pathology (IL-6, IL-1β, IFNγ, and IL-17a) were significantly suppressed in colon tissues from EV-treated mice. By contrast, high levels of the anti-inflammatory cytokine IL-10 were detected in Nb-EV-treated mice. Proteins and miRNAs contained within helminth EVs hold great potential application in development of drugs to treat helminth infections as well as chronic non-infectious diseases resulting from a dysregulated immune system, such as IBD.</p

    table_3_Hookworm Secreted Extracellular Vesicles Interact With Host Cells and Prevent Inducible Colitis in Mice.xlsx

    No full text
    <p>Gastrointestinal (GI) parasites, hookworms in particular, have evolved to cause minimal harm to their hosts, allowing them to establish chronic infections. This is mediated by creating an immunoregulatory environment. Indeed, hookworms are such potent suppressors of inflammation that they have been used in clinical trials to treat inflammatory bowel diseases (IBD) and celiac disease. Since the recent description of helminths (worms) secreting extracellular vesicles (EVs), exosome-like EVs from different helminths have been characterized and their salient roles in parasite–host interactions have been highlighted. Here, we analyze EVs from the rodent parasite Nippostrongylus brasiliensis, which has been used as a model for human hookworm infection. N. brasiliensis EVs (Nb-EVs) are actively internalized by mouse gut organoids, indicating a role in driving parasitism. We used proteomics and RNA-Seq to profile the molecular composition of Nb-EVs. We identified 81 proteins, including proteins frequently present in exosomes (like tetraspanin, enolase, 14-3-3 protein, and heat shock proteins), and 27 sperm-coating protein-like extracellular proteins. RNA-Seq analysis revealed 52 miRNA species, many of which putatively map to mouse genes involved in regulation of inflammation. To determine whether GI nematode EVs had immunomodulatory properties, we assessed their potential to suppress GI inflammation in a mouse model of inducible chemical colitis. EVs from N. brasiliensis but not those from the whipworm Trichuris muris or control vesicles from grapes protected against colitic inflammation in the gut of mice that received a single intraperitoneal injection of EVs. Key cytokines associated with colitic pathology (IL-6, IL-1β, IFNγ, and IL-17a) were significantly suppressed in colon tissues from EV-treated mice. By contrast, high levels of the anti-inflammatory cytokine IL-10 were detected in Nb-EV-treated mice. Proteins and miRNAs contained within helminth EVs hold great potential application in development of drugs to treat helminth infections as well as chronic non-infectious diseases resulting from a dysregulated immune system, such as IBD.</p

    image_1_Hookworm Secreted Extracellular Vesicles Interact With Host Cells and Prevent Inducible Colitis in Mice.tif

    No full text
    <p>Gastrointestinal (GI) parasites, hookworms in particular, have evolved to cause minimal harm to their hosts, allowing them to establish chronic infections. This is mediated by creating an immunoregulatory environment. Indeed, hookworms are such potent suppressors of inflammation that they have been used in clinical trials to treat inflammatory bowel diseases (IBD) and celiac disease. Since the recent description of helminths (worms) secreting extracellular vesicles (EVs), exosome-like EVs from different helminths have been characterized and their salient roles in parasite–host interactions have been highlighted. Here, we analyze EVs from the rodent parasite Nippostrongylus brasiliensis, which has been used as a model for human hookworm infection. N. brasiliensis EVs (Nb-EVs) are actively internalized by mouse gut organoids, indicating a role in driving parasitism. We used proteomics and RNA-Seq to profile the molecular composition of Nb-EVs. We identified 81 proteins, including proteins frequently present in exosomes (like tetraspanin, enolase, 14-3-3 protein, and heat shock proteins), and 27 sperm-coating protein-like extracellular proteins. RNA-Seq analysis revealed 52 miRNA species, many of which putatively map to mouse genes involved in regulation of inflammation. To determine whether GI nematode EVs had immunomodulatory properties, we assessed their potential to suppress GI inflammation in a mouse model of inducible chemical colitis. EVs from N. brasiliensis but not those from the whipworm Trichuris muris or control vesicles from grapes protected against colitic inflammation in the gut of mice that received a single intraperitoneal injection of EVs. Key cytokines associated with colitic pathology (IL-6, IL-1β, IFNγ, and IL-17a) were significantly suppressed in colon tissues from EV-treated mice. By contrast, high levels of the anti-inflammatory cytokine IL-10 were detected in Nb-EV-treated mice. Proteins and miRNAs contained within helminth EVs hold great potential application in development of drugs to treat helminth infections as well as chronic non-infectious diseases resulting from a dysregulated immune system, such as IBD.</p

    image_2_Hookworm Secreted Extracellular Vesicles Interact With Host Cells and Prevent Inducible Colitis in Mice.tif

    No full text
    <p>Gastrointestinal (GI) parasites, hookworms in particular, have evolved to cause minimal harm to their hosts, allowing them to establish chronic infections. This is mediated by creating an immunoregulatory environment. Indeed, hookworms are such potent suppressors of inflammation that they have been used in clinical trials to treat inflammatory bowel diseases (IBD) and celiac disease. Since the recent description of helminths (worms) secreting extracellular vesicles (EVs), exosome-like EVs from different helminths have been characterized and their salient roles in parasite–host interactions have been highlighted. Here, we analyze EVs from the rodent parasite Nippostrongylus brasiliensis, which has been used as a model for human hookworm infection. N. brasiliensis EVs (Nb-EVs) are actively internalized by mouse gut organoids, indicating a role in driving parasitism. We used proteomics and RNA-Seq to profile the molecular composition of Nb-EVs. We identified 81 proteins, including proteins frequently present in exosomes (like tetraspanin, enolase, 14-3-3 protein, and heat shock proteins), and 27 sperm-coating protein-like extracellular proteins. RNA-Seq analysis revealed 52 miRNA species, many of which putatively map to mouse genes involved in regulation of inflammation. To determine whether GI nematode EVs had immunomodulatory properties, we assessed their potential to suppress GI inflammation in a mouse model of inducible chemical colitis. EVs from N. brasiliensis but not those from the whipworm Trichuris muris or control vesicles from grapes protected against colitic inflammation in the gut of mice that received a single intraperitoneal injection of EVs. Key cytokines associated with colitic pathology (IL-6, IL-1β, IFNγ, and IL-17a) were significantly suppressed in colon tissues from EV-treated mice. By contrast, high levels of the anti-inflammatory cytokine IL-10 were detected in Nb-EV-treated mice. Proteins and miRNAs contained within helminth EVs hold great potential application in development of drugs to treat helminth infections as well as chronic non-infectious diseases resulting from a dysregulated immune system, such as IBD.</p

    table_4_Hookworm Secreted Extracellular Vesicles Interact With Host Cells and Prevent Inducible Colitis in Mice.xlsx

    No full text
    <p>Gastrointestinal (GI) parasites, hookworms in particular, have evolved to cause minimal harm to their hosts, allowing them to establish chronic infections. This is mediated by creating an immunoregulatory environment. Indeed, hookworms are such potent suppressors of inflammation that they have been used in clinical trials to treat inflammatory bowel diseases (IBD) and celiac disease. Since the recent description of helminths (worms) secreting extracellular vesicles (EVs), exosome-like EVs from different helminths have been characterized and their salient roles in parasite–host interactions have been highlighted. Here, we analyze EVs from the rodent parasite Nippostrongylus brasiliensis, which has been used as a model for human hookworm infection. N. brasiliensis EVs (Nb-EVs) are actively internalized by mouse gut organoids, indicating a role in driving parasitism. We used proteomics and RNA-Seq to profile the molecular composition of Nb-EVs. We identified 81 proteins, including proteins frequently present in exosomes (like tetraspanin, enolase, 14-3-3 protein, and heat shock proteins), and 27 sperm-coating protein-like extracellular proteins. RNA-Seq analysis revealed 52 miRNA species, many of which putatively map to mouse genes involved in regulation of inflammation. To determine whether GI nematode EVs had immunomodulatory properties, we assessed their potential to suppress GI inflammation in a mouse model of inducible chemical colitis. EVs from N. brasiliensis but not those from the whipworm Trichuris muris or control vesicles from grapes protected against colitic inflammation in the gut of mice that received a single intraperitoneal injection of EVs. Key cytokines associated with colitic pathology (IL-6, IL-1β, IFNγ, and IL-17a) were significantly suppressed in colon tissues from EV-treated mice. By contrast, high levels of the anti-inflammatory cytokine IL-10 were detected in Nb-EV-treated mice. Proteins and miRNAs contained within helminth EVs hold great potential application in development of drugs to treat helminth infections as well as chronic non-infectious diseases resulting from a dysregulated immune system, such as IBD.</p

    An outline of the development of the Czech sport financing after 1989

    No full text
    Title: An outline of the development of the Czech sport financing after 1989 Objectives: The main aim of this thesis is to analyse the development of the czech sport financing from the selected resources after 1989 till the present situation and it's prospect included in The concept sports funding 2016 - 2025 SPORT 2025 Methods: The basic method used in this thesis is the method of document analysis. Fundamental documents include legislative documents, especially The Lottery Act and its updating and The Act on Promotion of Sports. Aditional resources represent analytic and comparative studies prepared by ÄŒOV, ÄŒUS and MÅ MT conception. Another method is statistic analysis of quantitative data, in form of termporal lines, which are processed into basic charts and diagrams. Results: In recent 25 years have been significant changes in sports funding established. The turning point is considered the year 2011, when czech sport lost two stable financial resources. Primarily the company Sazka, a.s. went bankrupt, secondarily the amendment of the lottery act was accepted and has discontinued offtakes for public utility objects. Since then an optimal sports funding system is sought. State sports support shows a long-term downward trend and belongs to the lowest rank in the EU comparison. efforts to improve..

    Antibody-mediated IFNAR1 blockade boosts humoral immune responses during blood-stage infection.

    No full text
    <p>WT mice (n = 5/group) were treated with anti-IFNAR1 blocking antibody (α-Ifnar1) or control IgG prior to and during infection with <i>Pc</i>AS. (A) Representative FACS plots (gated on CD4<sup>+</sup> TCRβ<sup>+</sup> live singlets), proportions and absolute numbers of splenic ICOS<sup>+</sup> CD4<sup>+</sup> T cells in naïve and infected mice on days 6 and 7 <i>p</i>.<i>i</i>. (B) Representative FACS plots (gated on CD4<sup>+</sup> TCRβ<sup>+</sup> live singlets), proportions and numbers of splenic Tfh cells (as PD1<sup>+</sup>CXCR5<sup>+</sup> CD4<sup>+</sup> T cells) in naïve and infected and antibody-treated mice, 7 days <i>p</i>.<i>i</i>. Bcl-6 expression is also shown in histograms for Tfh (PD1<sup>+</sup>CXCR5<sup>+</sup>; red gate) and non-Tfh cells (PD1<sup>-</sup>CXCR5<sup>-</sup>; blue gate), alongside Geometric Mean Bcl-6 expression by these populations in individual mice. (C and D) Numbers of splenic (C) plasmablasts and (D) GC B cells in naïve, and infected and treated mice, 7 days <i>p</i>.<i>i</i>. Data representative of 2 independent experiments. Mann-Whitney U test *P<0.05; **P<0.01.</p

    Increased frequency of GITR-positive CD4<sup>+</sup> T cells in VL patients.

    No full text
    <p><b>A.</b> The relative expression of GITR mRNA in PBMC of VL patients was measured by qPCR before treatment (Pre-drug; n = 7) and 28 days after the commencement of treatment (Post-drug; n = 7),as well as in healthy endemic control (EC; n = 5) samples. <b>B</b>. PBMC’s from VL patients before drug treatment (VL; n = 7) and healthy endemic controls (EC; n = 5) were gated on CD3ε<sup>+</sup> CD4<sup>+</sup> T cells and the frequency of GITR-positive CD4<sup>+</sup> T cells was measured by FACS. Box and whisker plots show the box extending from the 25<sup>th</sup> to 75<sup>th</sup> percentiles with the line in the middle of the box representing the median and whiskers going down to the smallest value and up to the largest. Statistical differences of p < 0.05 (*) and p < 0.01 (**) are indicated.</p

    IFNAR1-signalling simultaneously limits splenic Th1 and Tfh cell responses.

    No full text
    <p>(A & B) Representative FACS plots (gated on CD4<sup>+</sup> TCRβ<sup>+</sup> live singlets), proportions and absolute numbers of splenic (A) Th1 (IFNγ<sup>+</sup> Tbet<sup>+</sup>) and (B) emerging Tfh (PD1<sup>+</sup> CXCR5<sup>+</sup>) cells in WT <i>and Ifnar1</i><sup><i>-/-</i></sup> mice (n = 6/group), 6 days <i>p</i>.<i>i</i> with <i>Pc</i>AS. Data representative of two independent experiments. (C) Numbers of splenic ICOS<sup>+</sup> Th1 cells (Tbet<sup>+</sup> IFNγ<sup>+</sup> CD4<sup>+</sup> T cells) and Tfh cells (PD1<sup>+</sup>CXCR5<sup>+</sup> CD4<sup>+</sup> T cells) 6 days <i>p</i>.<i>i</i>. with <i>Pc</i>AS. (D) Numbers of ICOS<sup>+</sup> Tfh cells (PD1<sup>+</sup>CXCR5<sup>+</sup> CD4<sup>+</sup> T cells), 16 days <i>p</i>.<i>i</i>. with <i>Py</i>17XNL infection. (E) Proportions and absolute numbers of splenic CD4<sup>+</sup> T-cells expressing Ki-67 in naïve, WT and <i>Ifnar1</i><sup><i>-/-</i></sup> mice 6 days <i>p</i>.<i>i</i>. with <i>Pc</i>AS. (F) Proportions and absolute numbers of splenic CD4<sup>+</sup> T-cells expressing Ki-67 in naïve mice, and WT mice, 6 days <i>p</i>.<i>i</i>. with <i>Py</i>17XNL and treatment with α-IFNAR1 or Control IgG. (G) Absolute numbers of splenocytes, CD4<sup>+</sup> T-cells and B-cells, in WT naïve, infected WT and <i>Ifnar1</i><sup><i>-/-</i></sup> mice 6 days (n = 17–18, pooled from three independent experiments (n = 5–6 per expt)) and 8 days (n = 29, pooled from five experiments (n = 5–6 per expt)) <i>p</i>.<i>i</i>. with <i>Pc</i>AS. (H) Absolute numbers of splenocytes, CD4<sup>+</sup> T-cells and B-cells in WT naïve, infected WT and <i>Ifnar1</i><sup><i>-/-</i></sup> mice, 16 days <i>p</i>.<i>i</i>. with <i>Py</i>17XNL (n = 17–18, pooled from three experiments (n = 5–6 per expt)) Mann-Whitney U-test **P<0.01, *P<0.05.</p
    corecore